View:
PULSE BIOSCIENCES, INC.
957 Point Eden Way
Hayward, California 94545
April 24, 2020
Via EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, NE
Division of Corporation Finance
Office of Life Sciences
100 F Street, NE
Washington, D.C. 20549-3561
|
Attention:
|
Mr. Jeffrey Gabor
|
|
Ms. Celeste Murphy
|
|
|
Re:
|
Pulse Biosciences, Inc.
|
|
Registration Statement on Form S-3
|
|
|
Filed April 6, 2020
|
|
|
File No. 333-237577
|
|
|
Withdrawal of Acceleration Request
|
Ladies and Gentlemen:
Pulse Biosciences, Inc. (the “Company”) hereby
respectfully requests withdrawal of its acceleration request filed on April 22, 2020, relating to its Registration Statement on Form S-3 (File No. 333-237577) (the
“Registration Statement”). The Company is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.
If you have any questions regarding the foregoing, please contact our counsel, Andrew D. Hoffman of Wilson Sonsini Goodrich & Rosati, P.C., at (650) 849-3240 or ahoffman@wsgr.com.
|
Sincerely,
|
||
|
PULSE BIOSCIENCES, INC.
|
||
|
By:
|
/s/ Sandra A. Gardiner
|
|
|
|
Sandra A. Gardiner | |
|
|
Chief Financial Officer, Executive Vice President of Finance and Administration, Secretary and Treasurer
|
|
|
cc:
|
Andrew D. Hoffman, Esq.,
|
|
Wilson Sonsini Goodrich & Rosati, P.C.
|